CB1/CB2 receptor agonists (Dimerix/University of Western Australia)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCB1/CB2 receptor agonists (Dimerix/University of Western Australia)
Drug Alias NameCannabinoid-1 and -2 receptor agonists (Dimerix/University of Western Australia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor agonistsCannabinoid CB2 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsPainInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDimerix Bioscience Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDimerix Bioscience Pty Ltd
Active IndicationsN/A
Inactive IndicationsPainInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A